Over 20 million people in the US are currently afflicted by rare disease. However, since the inception of the Orphan Drug Act in 1983, over 350 drugs have received approval by the FDA to combat these ailments- a significant increase from the 10 passed in the decade before. While this number is impressive, pharmaceutical companies still have a lot of ground to cover.
In support of Rare Disease Day, Siren Interactive created a visual representation of what these numbers truly mean and how people across the world are affected by these diseases. This infographic demonstrates what steps people are taking today to combat rare diseases the world-over. So where do we go from here?
Join us this July at the 2013 Orphan Drug Innovation Summit as we discuss new ways to look at orphan drug development and commercialization! Learn from some of the leading experts from the pharmaceutical industry, patient advocacy groups, venture capital groups and more as they teach attendees innovative techniques for clinical trials, market access, funding and building relationships that are sure to have a positive effect on the rare disease community!
In addition, to show our support for the 5th US Rare Disease Day, CBI will be donating a small portion of our proceeds from this year’s summit to benefit a patient organization helping to find a cure for a rare disease.